Acurian and Synexus Launch NASH Patient Enrollment Solution

Acurian Inc., a leading full-service provider of global patient enrollment and retention solutions, and Synexus, the leading global network of dedicated research sites, have launched a comprehensive solution for enrolling patients in clinical studies for nonalcoholic fatty liver disease (NAFLD) and its advanced form, nonalcoholic steatohepatitis (NASH).

23 Apr. 2018

PPD Expands GMP Biologics Testing Capacity

PPD has expanded its GMP (good manufacturing practices) analytical laboratory in Middleton, Wisconsin.

28 Mar. 2018

PPD and Acurian Introduce Innovative Patient Concierge Service for Clinical Trials

PPD and Acurian, the leading full-service provider of global patient enrollment and retention solutions and a subsidiary of PPD, announced a new patient concierge service designed to make it easier for patients and their caregivers to participate in clinical trials and to help pharmaceutical and biotechnology clients retain patients.

28 Feb. 2018

PPD Recognized for Superior Employee Development

PPD announced it has been honored for employee learning and development programs that help the global contract research organization deliver service excellence to its pharmaceutical and biotechnology clients.

21 Feb. 2018

PPD Names Maria Teresa Hilado, CFO of Allergan, to its Board of Directors

PPD announced that Maria Teresa Hilado, chief financial officer of Allergan, has been named to PPD’s board of directors.

01 Feb. 2018

PPD and Quotient Sciences Form Innovative Partnership to Accelerate Pediatric Drug Development

PPD and Quotient Sciences announced a new collaboration to accelerate pediatric drug development.

16 Jan. 2018

PPD® Laboratories Named a Top Innovator in Drug Development

PPD announced that PPD® Laboratories has been recognized as a 2018 top innovator in drug development by CenterWatch, a leading publisher of clinical trials information for clinical research professionals.

05 Jan. 2018

PPD Names Colin Hill, CEO of GNS Healthcare, to its Board of Directors

PPD announced that Colin Hill has been named to the company’s board of directors. Hill is the chairman, chief executive officer and co-founder of GNS Healthcare, a leading precision medicine company.

03 Jan. 2018

Media Contacts:

Randy Buckwalter Senior Manager, Corporate Communications
Tel: +1 919 456 4425

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2018 Pharmaceutical Product Development, LLC. All rights reserved.